Compare Davita Inc (DVA) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs PepsiCo, Inc. — how do they compare? Davita Inc trades at $227.08 (market cap $14.92B), while PepsiCo, Inc. trades at $135.93 (market cap $184.87B). The key difference: PepsiCo, Inc. is far larger — about 12.4× Davita Inc's market cap, and PepsiCo, Inc. pays a 4.37% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | PEP | |
|---|---|---|
Market Cap | $14.92B | $184.87B |
Sector | Health | Consumer Staples |
52-Week High | $235.71 | $170.44 |
52-Week Low | $103.87 | $133.81 |
Enterprise Value | $27.47B | $227.37B |
Dividend Yield | — | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
PepsiCo (PEP) trades at $135.11, down 2.44% over the past day, with a bearish technical outlook. The stock shows strong profitability with a 10.78% net income margin and 51.59% ROE, though revenue growth remains modest. Recent earnings have consistently beaten estimates, and the company maintains a solid dividend. However, price pressures on snacks and high debt levels pose challenges. Analyst consensus is a 'Hold' with a $159.27 price target, indicating potential upside from current levels.
The outlook for PEP is mixed: fundamentals are robust with earnings beats and high returns, but technicals and sentiment are cautious. Investment opportunity lies in valuation discount to analyst targets and dividend yield, while risks include consumer pushback on pricing, competitive pressures, and leverage. Near-term performance hinges on Q3 2026 earnings and North American segment recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
